FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Chiesi Zileuton Extended-Release Tablets Recall

Zileuton Extended-Release Tablets, 600 mg, 120-count bottles, Rx only, Distributed by:…

Chiesi USA, Inc. · Cary, NC

Risk level
Class II
Reported by FDA
Jun 19, 2019
Recall ID
D-1342-2019
Check your lot numberHow we source this data

Summary

Chiesi recalled Zileuton Extended-Release Tablets starting May 31, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1342-2019 on Jun 19, 2019. Reason: Failed Dissolution Specifications: Out of specification result for dissolution. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Out of specification result for dissolution.

Product description

Zileuton Extended-Release Tablets, 600 mg, 120-count bottles, Rx only, Distributed by: Prasco Laboratories, Mason, OH 45040 USA; NDC 66993-485-32.

Lot numbers, UPCs & expiration codes

Lots: 3171856, Exp. 12/19

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1342-2019
Classification
Class II
Status
Terminated
Recall initiated
May 31, 2019
FDA report date
Jun 19, 2019
Quantity
2598 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Chiesi USA, Inc.

Original FDA data

Every field from FDA enforcement report D-1342-2019, exactly as published.

Show all FDA fields
City
Cary
State
NC
Status
Terminated
Country
United States
Event ID
82993
Address
175 Regency Woods Place, Ste. 600
Code information
Lots: 3171856, Exp. 12/19
Postal code
27518-8128
Report date
Jun 19, 2019
Product type
Drugs
Recall number
D-1342-2019
Classification
Class II
Recalling firm
Chiesi USA, Inc.
Product quantity
2598 bottles
Termination date
Mar 8, 2021
Reason for recall
Failed Dissolution Specifications: Out of specification result for dissolution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zileuton Extended-Release Tablets, 600 mg, 120-count bottles, Rx only, Distributed by: Prasco Laboratories, Mason, OH 45040 USA; NDC 66993-485-32.
Distribution pattern
Nationwide in the USA.
Recall initiation date
May 31, 2019
Initial firm notification
Letter
Center classification date
Jun 13, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1342-2019, published Jun 19, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls